Frank B. McGuyer
Gründer bei McGuyer Homebuilders, Inc.
Profil
Frank B.
McGuyer is the founder.
He founded McGuyer Homebuilders, Inc. in 1988 and currently holds the title of Executive Chairman.
He also served as an Independent Director at Bellicum Pharmaceuticals, Inc. from 2009 to 2018.
In terms of education, Mr. McGuyer attended Southern Methodist University where he obtained an undergraduate degree.
Aktive Positionen von Frank B. McGuyer
| Unternehmen | Position | Beginn |
|---|---|---|
McGuyer Homebuilders, Inc.
 McGuyer Homebuilders, Inc. HomebuildingConsumer Durables McGuyer Homebuilders, Inc. builds single-family residential homes. It markets homes under the brand names Coventry Homes, Pioneer Homes and Plantation Homes. The company was founded by Frank B. McGuyer and Mike Love in 1988 and is headquartered in Houston, TX. | Gründer | 01.01.1988 |
Ehemalige bekannte Positionen von Frank B. McGuyer
| Unternehmen | Position | Ende |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 20.12.2018 |
Ausbildung von Frank B. McGuyer
| Southern Methodist University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
McGuyer Homebuilders, Inc.
McGuyer Homebuilders, Inc. HomebuildingConsumer Durables McGuyer Homebuilders, Inc. builds single-family residential homes. It markets homes under the brand names Coventry Homes, Pioneer Homes and Plantation Homes. The company was founded by Frank B. McGuyer and Mike Love in 1988 and is headquartered in Houston, TX. | Consumer Durables |
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
